AzTrials
AzTrials

HealthyNCT05294471

Fully Automated High-Throughput Quantitative MRI of the Liver

An observational study of Healthy and Iron Overload, run by University of Wisconsin, Madison at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this research is to see if a new automated magnetic resonance imaging (MRI) method will be able to improve the images taken of the liver. Participants will have either known or suspected liver disease, known or suspected iron overload syndrome, or be a healthy adult. Read more about this study

Who is it for?
Ages 7 years and olderHealthy volunteers can take part
Conditions the study is for
Healthy, Iron Overload, Liver Fat
What is being tested?
Non-contrast MRI with novel MRI software
Type of treatment
Medical device
How many people
204 participants
Where
1 siteUnited States
Study dates
16 Oct 2023to Oct 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Healthy volunteers will be recruited from the "MRI Volunteer Database", and/or UW - Madison employees. Participants with liver fat or liver iron will be recruited from relevant UW Clinics.

Who may be able to join

  • Age 18 years or older
  • Age 7 years or older
  • One of:
  • Known or suspected liver iron overload
  • Known or suspected elevated liver fat
  • Age 7 years or older
  • Scheduled for a clinical abdominal MRI exam

Who cannot join

  • Patients with contraindication to MRI (e.g. pacemaker, contraindicated metallic implants, claustrophobia, etc)
  • Pregnant or trying to become pregnant (as determined by self-report during MRI safety screening)
  • Eligibility Criteria for Substudy 3
  • Patients with contraindication to MRI (e.g. pacemaker, contraindicated metallic implants, claustrophobia, etc)
  • Patients requiring intravenous (IV) conscious sedation for imaging are not eligible; patients requiring mild, oral anxiolytics for the MRI will be allowed to participate as long as the following criteria are met:
  • The subject has their own prescription for the medication.
Show all 13Show fewer
  • The informed consent process is conducted prior to the self-administration of this medication
  • They come to the research visit with a driver
  • Pregnant or trying to become pregnant (as determined by self-report during MRI safety screening)
  • Eligibility Criteria for Substudy 6
  • Patients with contraindication to MRI (e.g. pacemaker, contraindicated metallic implants, claustrophobia, etc)
  • Sedation required for MRI
  • Pregnant or trying to become pregnant (as determined by self-report during MRI safety screening)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Radiology Studies contact

608-282-8349

radstudy@uwhealth.org

United States1 site, 1 recruiting
  • University of Wisconsin

    Madison, Wisconsin, 53705

    Scott Reeder, MD, PhD

    Recruiting

Other trials in United States

About this study

The purpose of this research is to see if a new automated magnetic resonance imaging (MRI) method will be able to improve the images taken of the liver. Participants will have either known or suspected liver disease, known or suspected iron overload syndrome, or be a healthy adult. Participants will be in the research study for one day.

Read the detailed description

The overall purpose of this work is to develop, implement and test a "single-button push", integrated combination of innovative MRI solutions to enable low-cost quantitative evaluation of chronic liver disease in less than 5 minutes of true MRI suite time. The aim is to design a reliable, low variability, fully automated, highly efficient MRI exam.

The primary objective is to demonstrate a free-breathing 2D CSE-MRI method that is robust to motion and free of bias when compared to the reference 3D CSE-MRI method.

Secondary objectives include optimization of the methods in healthy volunteers, and technical success and throughput of the single-button push exam:

  1. Repeatability: we will calculate the squared difference between each pair of repeated proton density fat fraction (PDFF) / R2* measurements, and will model this value including the acquisition/reconstruction method as a covariate using Generalized Estimating Equations (GEE)
  2. Reproducibility of the proposed method between 1.5T and 3T using the reproducibility coefficient and interclass correlation coefficient (ICC)
  3. Technical success of the single-push button exam (completion of exam, acceptable automated prescription as determined through radiologist evaluation, image quality, and automated analysis accuracy compared to manual analysis)
  4. Mean and standard deviation of total two-door suite time for the single-push button exam

Specific Aims:

Aim 1: Develop and optimize motion-insensitive, high-SNR (signal-to-noise ratio), free-breathing "error-proof" CSE-MRI for accurate and precise measurement of PDFF and R2* as biomarkers of liver fat and iron.

Aim 2: Confirm the accuracy (ie: bias) and precision (ie: repeatability, and reproducibility across field strength) of the proposed CSE-MRI method in patients with liver steatosis and in patients with liver iron overload.

Aim 3: Implement and validate an integrated single-button push, fully automated CSE-MRI protocol in < 5 minutes of MR room time, using i) Artificial intelligence (AI)-based automated image prescription, ii) an innovative MRI "Smart Suite" design, and iii) automated quantitative image analysis and reporting.

To accomplish these aims, participants will be recruited for 6 substudies:

  1. Substudy 1: Optimization of free breathing 2D CSE method in healthy volunteers
  2. Substudy 2: Validation of free breathing 2D CSE method in healthy volunteers
  3. Substudy 3: Validation in patients with known or suspected iron overload or fatty liver
  4. Substudy 4: Evaluation of auto-prescription in healthy volunteers
  5. Substudy 5: Round-robin evaluation of single-push button exam in healthy volunteers
  6. Substudy 6: Throughput evaluation in patients scheduled for clinical abdominal MRI

For substudies 1, 2, and 4 participants will be asked to complete one research visit lasting approximately 1.5 hours. Participants will be scanned at a single field strength for up to 1 hour. To assess test-retest repeatability, subjects may be asked to sit up on the MRI scanner bed, or step off then back on to the scanner.

In substudy 3, participants will be asked to complete one research visit lasting approximately 1.5 hours. Participants will be scanned on a 1.5T system for up to 1 hour. In order to demonstrate the reproducibility across field strength of CSE MRI to measure liver iron and fat, 10 participants with liver fat and 10 participants with liver iron will be scanned a second time on the same day at 3T. For these 20 participants, total scan time be less than 2 hours and the study visit will last approximately 3 hours.

In substudy 5, the study visit will last approximately 3.5 hours. Participants will participate in groups of 10. After consenting, MRI screening, and anthropometric measurements, participants will form a queue and be scanned consecutively. After scanning, each participant will rejoin the end of the queue. Each participant will be scanned 3 times. Each individual scanning "session" will last approximately 5 minutes, and each participants total scan time will be less than 20 minutes.

Each participant in substudy 5 will be equipped with a Smart Suite RFID (radio frequency identification) or Bluetooth bracelet system to track MRI suite time for each participant and scan. The bracelets are also used in clinical imaging visits to track patient workflow. The bracelet will be used to track when participants enter and leave the MRI suite. The relative timings from baseline will be recorded automatically, entered into the study RedCap and linked with other study data via the participant's Study ID.

For substudy 6, prior to their clinical exam, participants will be scanned with the single-button push protocol. The research scan time will be less than 10 minutes and the total research visit will last approximately 20 minutes. Each participant in this substudy will also be equipped with a Smart Suite RFID or Bluetooth bracelet system to track MRI suite time for each participant and scan, as described for substudy 5.

Being tested
Non-contrast MRI with novel MRI software
Medical subject headings
Iron Overload, Fatty Liver

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Non-contrast MRI with novel MRI softwareDevice

    The investigational software being used in automatic prescription of the imaging is an application of an AI algorithm. This software prescribes where the MRI system will take images by finding the liver within a set of localizer scans. The software gives coordinates to the scanner.

Study groups in NCT05294471
Study groupRoleWhat they receive
Healthy participants70 healthy participants will be recruited, across substudies 1, 2, 4, and 5
Receives: Device: Non-contrast MRI with novel MRI software
Participants with known or suspected iron overload30 Participants with known or suspected iron overload will be recruited, to substudy 3
Receives: Device: Non-contrast MRI with novel MRI software
Participants with elevated levels of liver fat30 participants with elevated levels of liver fat will be recruited, to substudy 3
Receives: Device: Non-contrast MRI with novel MRI software
Participants referred for clinical abdominal MRI60 participants referred for clinical abdominal MRI will be recruited, to substudy 6
Receives: Device: Non-contrast MRI with novel MRI software

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Confirm the accuracy (ie: bias) of the proposed CSE-MRI method in patients with liver steatosis and in patients with liver iron overload

    For each liver segment, and for whole-liver PDFF and R2* measurements, we will determine bias of CSE 2D using CSE 3D BH as the reference from Bland-Altman analysis.

    The range of R2* values leading to reliable measurements of PDFF and R2* will be determined using a two-segment piecewise linear model with the change point estimated from the data.

    Measured: 1 day (1 study visit, up to 3.5 hours)

Secondary outcomes (5)
  1. Image quality of free breathing 2D chemical shift encoded (CSE) method

    Image quality for each acquisition will be evaluated by 3 radiologists, using a Likert scale between 0 (worst/non-diagnostic) and 3 (best) for criteria including: motion artifacts, spatial resolution, SNR (signal- to-noise ratio), and overall image quality.

    Measured: 1 day (1 study visit, up to 3.5 hours)

  2. Measure the repeatability of the proposed CSE-MRI method in patients with liver steatosis and in patients with liver iron overload

    To compare repeatability for various acquisition/reconstruction methods, we will calculate the squared difference between each pair of repeated PDFF / R2* measurements, and will model this value including the acquisition/reconstruction method as a covariate using Generalized Estimating Equations (GEE), with subject as a random factor to account for within-subject correlation. This analysis will be performed for all liver segments and whole-liver measurements. Further, the repeatability coefficient will also be assessed separately for each method. Bland-Altman plots will also be used to visualize the repeatability profile over the PDFF / R2* range. The automated vs manual PDFF / R2* measurements will be evaluated for each acquisition.

    Measured: 1 day (1 study visit, up to 3.5 hours)

  3. Confirm the reproducibility of the proposed CSE-MRI method across field strengths

    The reproducibility of the proposed method between 1.5T and 3T will be evaluated in two ways. First, at each field strength, PDFF and R2* will each be compared between FB FAM CSE and BH CSE 3D (as the reference), using Bland Altman analysis to assess the bias. Second, PDFF will be compared between 1.5T and 3T using Bland Altman analysis for each method, based on the expected field strength independence of PDFF. R2* will also be compared between 1.5T and 3T for each method, after converting to liver iron concentration (LIC, mg/g) using the 1.5T and 3T calibrations determined by our group, to compensate for the effect of field strength on R2*. In all comparisons, the reproducibility coefficient, and interclass correlation coefficient (ICC) with 95% confidence intervals will be calculated to quantify the degree of reproducibility.

    Measured: 1 day (1 study visit, up to 3.5 hours)

  4. Technical success rate of the integrated single-button push, fully automated CSE-MRI protocol in < 5 minutes of MR room time

    The technical success rate of the integrated single-button push, fully automated CSE-MRI exam will be determined through completion rate of the exam in less than 5 minutes, radiologist evaluation of image quality using a Likert scale, and accuracy of the automated analysis compared to manual evaluation.

    Measured: 1 day (1 study visit, up to 3.5 hours)

  5. Mean and standard deviation of total two-door suite time for the single-push button exam

    Throughput of the single-button push exam will be quantified by: throughput (subjects/hour), suite time per subject (mean, standard deviation, median, and quartiles) and suite time components (eg: room turnaround time, prescan/scan time for each series).

    Measured: 1 day (1 study visit, up to 3.5 hours)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Mar 2022
  2. Study start16 Oct 2023
  3. Primary completionOct 2026 (estimated)
  4. Study completionOct 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
204 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05294471
Sponsor's protocol ID
2021-1615
Other IDs
2021-1615, A539300, SMPH/RADIOLOGY/RADIOLOGY, 2/18/2025, 1R01EB031886-01A1
Status last verified
Mar 2026
First submitted
15 Mar 2022
Last updated
16 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Healthy and Iron Overload, run by University of Wisconsin, Madison at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 16 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Radiology Studies (608-282-8349, radstudy@uwhealth.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Confirm the accuracy (ie: bias) of the proposed CSE-MRI method in patients with liver steatosis and in patients with liver iron overload (time frame: 1 day (1 study visit, up to 3.5 hours)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in